Skip to content

Clinical trials

Phase 2 Congenital Abnormalities trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Phase: Phase 2 Country / region: United Kingdom Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vion Pharmaceuticals2
Imperial College London1
Merck Sharp & Dohme LLC1
Mirum Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities5
Leukemia2
Leukemia, Myeloid, Acute2
Bile Duct Diseases1
Biliary Atresia1
Biliary Tract Diseases1
Hereditary Sensory and Autonomic Neuropathies1
Leukemia, Basophilic, Acute1
Leukemia, Eosinophilic, Acute1
Leukemia, Erythroblastic, Acute1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.